CoChat

Caffeic acid phenethyl ester protects nigral dopaminergic neurons via dual mechanisms involving haem oxygenase‐1 and brain‐derived neurotrophic factor

Open access
Kurauchi, Y, Hisatsune, A, Isohama, Y, Mishima, S, Katsuki, H · 2012 · British Journal of Pharmacology
Cited by 83

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

BACKGROUND AND PURPOSE: Caffeic acid phenethyl ester (CAPE) is a component of honey bee propolis that can induce expression of haem oxygenase‐1 (HO‐1). Because HO‐1 induction has been suggested to protect dopaminergic neurons in the substantia nigra, we examined the effect of CAPE in experimental models of dopaminergic neurodegeneration. EXPERIMENTAL APPROACH: Neuroprotective effect of CAPE was investigated in rat organotypic midbrain slice cultures and in vivo, using a mouse model of dopaminergic neurodegeneration induced by intranigral injection of LPS and intrastriatal injection of 6‐hydroxydopamine. KEY RESULTS: CAPE protected dopaminergic neurons in slice cultures from IFN‐γ/LPS‐induced injury. The effect of CAPE was inhibited by zinc protoporphyrin IX, an HO‐1 inhibitor, and by neutralizing antibody against brain‐derived neurotrophic factor (BDNF). A p38 MAPK inhibitor SB203580 prevented activation of NF‐E2‐related factor 2, attenuated increased expression of HO‐1 and BDNF, and blocked the neuroprotective actions of CAPE. In the LPS‐injected mouse model, daily intraperitoneal administration of CAPE protected dopaminergic neurons, up‐regulated HO‐1 and BDNF, and reduced the increase of activated microglia/macrophages. Neuroprotective effects of CAPE against LPS‐induced injury was prevented by zinc protoporphyrin IX or anti‐BDNF antibody. CAPE protected dopaminergic neurons and alleviated methamphetamine‐induced rotational behaviour also in 6‐hydroxydopamine hemiparkinsonian mice. CONCLUSION AND IMPLICATIONS: CAPE is a novel type of neuroprotective agent whose actions are mediated by both HO‐1 and BDNF. These findings may provide novel clues to develop neuroprotective agents for treatment of neurodegenerative disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.2012.01833.x

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 83

Metadata

Authors
Kurauchi, Y., Hisatsune, A., Isohama, Y., Mishima, S., & Katsuki, H.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2012-05-08
Volume
166
Issue
3
Pages
1151-1168
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1480863120
Cited by
83
References
7
FWCI
4.67
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Caffeic acid phenethyl ester protects nigral dopaminergic neurons via dual mechanisms involving haem oxygenase‐1 and brain‐derived neurotrophic factor. https://app.cochat.ai/papers/10.1111/j.1476-5381.2012.01833.x
The paper
Kurauchi, Y., Hisatsune, A., Isohama, Y., Mishima, S., & Katsuki, H. (2012). Caffeic acid phenethyl ester protects nigral dopaminergic neurons via dual mechanisms involving haem oxygenase‐1 and brain‐derived neurotrophic factor. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2012.01833.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.